When uncontrolled diabetes mellitus and severe covid-19 converge: The perfect storm for mucormycosis

311Citations
Citations of this article
356Readers
Mendeley users who have this article in their library.

Abstract

Mucormycosis (MCR) has been increasingly described in patients with coronavirus disease 2019 (COVID-19) but the epidemiological factors, presentation, diagnostic certainty, and outcome of such patients are not well described. We review the published COVID-19-associated mucormycosis (CAMCR) cases (total 41) to identify risk factors, clinical features, and outcomes. CAMCR was typically seen in patients with diabetes mellitus (DM) (94%) especially the ones with poorly controlled DM (67%) and severe or critical COVID-19 (95%). Its presentation was typical of MCR seen in diabetic patients (mostly rhino-orbital and rhino-orbital-cerebral presentation). In sharp contrast to reported COVID-associated aspergillosis (CAPA) cases, nearly all CAMCR infections were proven (93%). Treating physicians should have a high suspicion for CAMCR in patients with uncontrolled diabetes mellitus and severe COVID-19 presenting with rhino-orbital or rhino-cerebral syndromes. CAMR is the convergence of two storms, one of DM and the other of COVID-19.

Cite

CITATION STYLE

APA

John, T. M., Jacob, C. N., & Kontoyiannis, D. P. (2021, April 1). When uncontrolled diabetes mellitus and severe covid-19 converge: The perfect storm for mucormycosis. Journal of Fungi. MDPI AG. https://doi.org/10.3390/jof7040298

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free